Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients.
Saved in:
| Title: | Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients. |
|---|---|
| Authors: | Liuhto, Niilo1 (AUTHOR) niilo.liuhto@varha.fi, Tuominen, Jenni2 (AUTHOR), Manni, Noora1 (AUTHOR), Hakamäki, Markus1 (AUTHOR), Lankinen, Roosa1 (AUTHOR), Toukola, Tomi3 (AUTHOR), Virtanen, Jonna1 (AUTHOR), Metsärinne, Kaj1 (AUTHOR), Järvisalo, Mikko J.4 (AUTHOR), Hellman, Tapio1 (AUTHOR) |
| Source: | PLoS ONE. 7/7/2026, Vol. 21 Issue 7, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0353258 |
